Large Cap · Healthcare · Biotechnology
Large Cap · Healthcare · Biotechnology
Get the AI take on MRNA
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
47/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$25
Median target
$45
Current price
$62.95
Highest
$79
Forward P/E
No signal · Not enough data to judge
-
Price / sales
Rich · Priced well above what its revenue alone supports
11.35x
Price / FCF
No signal · Not enough data to judge
-
EV / EBITDA
No signal · Not enough data to judge
-
ROIC
Weak · Struggling to earn much on the capital it uses
-76.0%
ROE
Needs attention · Unfavorable
-39.0%
Debt / equity
Favorable · 0.18 - strong leverage
0.19x
Current ratio
Strong · Comfortable room to cover bills due within a year
2.29x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $25.28B | - | -27.6% | 47 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |